Study Evaluating Effectiveness of Ziprasidone Using the Overlapped Switching Strategy in Patients With Schizophrenia or Schizoaffective Disorder.
Phase of Trial: Phase IV
Latest Information Update: 24 Nov 2014
At a glance
- Drugs Ziprasidone (Primary)
- Indications Schizoaffective disorder; Schizophrenia
- Focus Therapeutic Use
- 18 Nov 2014 According to the ClinicalTrials.gov record, status changed from recruiting to completed.
- 22 Jul 2011 Planned End Date changed from 1 Dec 2011 to 1 Jun 2012 as reported by ClinicalTrials.gov.
- 22 Jul 2011 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.